2024 Speakers

 

Suchismita Acharya, Chief Executive Officer, AyuVis Research

Suchismita Acharya | Chief Executive Officer | AyuVis Research » speaking at Orphan Drug Congress

Samuel Agyei Wiafe, Executive Director, Rare Disease Ghana Initiative

Samuel Agyei Wiafe | Executive Director | Rare Disease Ghana Initiative » speaking at Orphan Drug Congress

Dennis Akkaya, Chief Commercial Officer, myTomorrows

Dennis Akkaya | Chief Commercial Officer | myTomorrows » speaking at Orphan Drug Congress

David Allison, Chief Executive Officer, TREAT-NMD

David Allison | Chief Executive Officer | TREAT-NMD » speaking at Orphan Drug Congress

Derek Ansel, Executive Director, Therapeutic Strategy Lead, Rare Diseases, Worldwide Clinical Trials

Derek Ansel | Executive Director, Therapeutic Strategy Lead, Rare Diseases | Worldwide Clinical Trials » speaking at Orphan Drug Congress

Irina Antonijevic, Chief Medical Officer, EveryONE Medicines

Irina Antonijevic | Chief Medical Officer | EveryONE Medicines » speaking at Orphan Drug Congress

Victoria Arteaga, Co-founder, SHER Hispanic Society for Rare Diseases

Victoria Arteaga | Co-founder | SHER Hispanic Society for Rare Diseases » speaking at Orphan Drug Congress

Ethan Ash, Senior VP of Business Development, BioNews

Ethan Ash | Senior VP of Business Development | BioNews » speaking at Orphan Drug Congress

Kevin Bagley, Former Medicaid Director for State of Nebraska | Consultant, Kevin Bagley Strategic Consulting

Kevin Bagley | Former Medicaid Director for State of Nebraska | Consultant | Kevin Bagley Strategic Consulting » speaking at Orphan Drug Congress

Mark Bainbridge, Senior Director, Business Development, Early Access, Inceptua Group

Mark Bainbridge | Senior Director, Business Development, Early Access | Inceptua Group » speaking at Orphan Drug Congress

Ritu Baral, Managing Director And Senior Biotechnology Analyst, Cowen

Ritu Baral | Managing Director And Senior Biotechnology Analyst | Cowen » speaking at Orphan Drug Congress

Ron Bartek, President, Co-Founder, Friedreich's Ataxia Research Alliance

Ron Bartek | President, Co-Founder | Friedreich's Ataxia Research Alliance » speaking at Orphan Drug Congress

Kevin Baruzzi, Partner, Simon-Kucher & Partners Strategy & Marketing Consultants GmbH

Kevin Baruzzi | Partner | Simon-Kucher & Partners Strategy & Marketing Consultants GmbH » speaking at Orphan Drug Congress

Stuart Bell, Senior Vice President, Inceptua Early Access, Inceptua Group

Stuart Bell | Senior Vice President, Inceptua Early Access | Inceptua Group » speaking at Orphan Drug Congress

Jana Benesh, Director of Therapeutic Expertise, ICON Centre for Rare Diseases

Jana Benesh | Director of Therapeutic Expertise | ICON Centre for Rare Diseases » speaking at Orphan Drug Congress

Kara Berasi, Chief Executive Officer, Haystack Project

Kara Berasi | Chief Executive Officer | Haystack Project » speaking at Orphan Drug Congress

Alexandre Bétourné, Executive Director, Critical Path Institute

Alexandre Bétourné | Executive Director | Critical Path Institute » speaking at Orphan Drug Congress

Sulagna Bhattacharya, Chief Executive Officer, Nanoscope Therapeutics

Sulagna Bhattacharya | Chief Executive Officer | Nanoscope Therapeutics » speaking at Orphan Drug Congress

Robin Bliss, VP Strategic Consultant, Veristat

Robin Bliss | VP Strategic Consultant | Veristat » speaking at Orphan Drug Congress

Lara Bloom, President and CEO, The Ehlers-Danlos Society

Lara Bloom | President and CEO | The Ehlers-Danlos Society » speaking at Orphan Drug Congress

Adam Bloomfield, M.D., FAAP, Vice President, Medical Affairs, Rare Diseases and Pediatrics, Premier Research

Adam Bloomfield, M.D.,  FAAP | Vice President, Medical Affairs, Rare Diseases and Pediatrics | Premier Research » speaking at Orphan Drug Congress

Morgan Boname, Senior Director, Public Policy, Neurocrine Biosciences

Morgan Boname | Senior Director, Public Policy | Neurocrine Biosciences » speaking at Orphan Drug Congress

Natasha Bonhomme, Founder, Expecting Health

Natasha Bonhomme | Founder | Expecting Health » speaking at Orphan Drug Congress

James Boomhower MS(c), FP-C, NR-P, CCISM, Code Rare EMS Educator, Rare Strides

James Boomhower MS(c), FP-C, NR-P, CCISM | Code Rare EMS Educator | Rare Strides » speaking at Orphan Drug Congress

Wendy Borsari, Sr. Manager of Patient Advocacy, Tenaya Therapeutics

Wendy Borsari | Sr. Manager of Patient Advocacy | Tenaya Therapeutics » speaking at Orphan Drug Congress

Julie Breneiser, Executive Director, Gorlin Syndrome Alliance

Julie Breneiser | Executive Director | Gorlin Syndrome Alliance » speaking at Orphan Drug Congress

P.J. BROOKS, Deputy Director of the NCATS Division of Rare Diseases Research Innovation, National Institutes of Health

P.J. BROOKS | Deputy Director of the NCATS Division of Rare Diseases Research Innovation | National Institutes of Health » speaking at Orphan Drug Congress

Benjamin Brown, Executive Director, American Society of Pharmacovigilance

Benjamin Brown | Executive Director | American Society of Pharmacovigilance » speaking at Orphan Drug Congress

Bert Bruce, US Rare Disease Lead, Pfizer, Pfizer

Bert Bruce | US Rare Disease Lead, Pfizer | Pfizer » speaking at Orphan Drug Congress

Chuck Bucklar, Principal, Chair 5 Consulting, LLC

Chuck Bucklar | Principal | Chair 5 Consulting, LLC » speaking at Orphan Drug Congress

Karin Butler, Head of Technical Research, York Health Economics Consortium

Karin Butler | Head of Technical Research | York Health Economics Consortium » speaking at Orphan Drug Congress

Lauren Bylsma, Senior Epidemiologist, EpidStrategies, A Division of ToxStrategies

Lauren Bylsma | Senior Epidemiologist | EpidStrategies, A Division of ToxStrategies » speaking at Orphan Drug Congress

Amanda Cali, Trustee,The Radiant Hope Foundation; Trustee,Ian Cali FOP Research Fund at University of PA; Co-Founder/Officer, Tin Soldiers Global

Amanda Cali | Trustee,The Radiant Hope Foundation; Trustee,Ian Cali FOP Research Fund at University of PA; Co-Founder/Officer | Tin Soldiers Global » speaking at Orphan Drug Congress

Robert M. Califf, Commissioner, U.S. Food and Drug Administration

Robert M. Califf | Commissioner | U.S. Food and Drug Administration » speaking at Orphan Drug Congress

Joshua Card-Gowers, Senior Evidence Lead, HealthLumen

Joshua Card-Gowers | Senior Evidence Lead | HealthLumen » speaking at Orphan Drug Congress

Madeleine Carrier, Patient Navigator, myTomorrows

Madeleine Carrier | Patient Navigator | myTomorrows » speaking at Orphan Drug Congress

Geoffrey Case, Digital Editor, RARE Revolution Magazine

Geoffrey Case | Digital Editor | RARE Revolution Magazine » speaking at Orphan Drug Congress

Cynthia Cassandro, Vice President, Patient Advoacy, Vigil Neuroscience

Cynthia Cassandro | Vice President, Patient Advoacy | Vigil Neuroscience » speaking at Orphan Drug Congress

Grant Castor, SVP Commercial Strategy & Operations, Sentynl Therapeutics

Grant Castor | SVP Commercial Strategy & Operations | Sentynl Therapeutics » speaking at Orphan Drug Congress

Chelsea Catsburg, Engagement Manager, BluePrint Orphan

Chelsea Catsburg | Engagement Manager | BluePrint Orphan » speaking at Orphan Drug Congress

Anne-Sophie Chalandon, Head of Global Public Affairs, Rare Diseases and CGT Policies, Sanofi

Anne-Sophie Chalandon | Head of Global Public Affairs, Rare Diseases and CGT Policies | Sanofi » speaking at Orphan Drug Congress

James Chambers, Associate Professor, Tufts Medical Center

James Chambers | Associate Professor | Tufts Medical Center » speaking at Orphan Drug Congress

Chere Chapman, Chief Executive Officer, Ardea Outcomes

Chere Chapman | Chief Executive Officer | Ardea Outcomes » speaking at Orphan Drug Congress

Richard Chapman, Chief Science Officer, Innovation and Value Initiative

Richard Chapman | Chief Science Officer | Innovation and Value Initiative » speaking at Orphan Drug Congress

Ellen Cho, Director, Specialty Programs, Direct Relief

Ellen Cho | Director, Specialty Programs | Direct Relief » speaking at Orphan Drug Congress

Priya S Chockalingam, Vice President, Head of Clinical Bioanalytics & Translational Sciences, Beam Therapeutics

Priya S Chockalingam | Vice President, Head of Clinical Bioanalytics & Translational Sciences | Beam Therapeutics » speaking at Orphan Drug Congress

Duane Clark, General Manager, US Rare Disease, SANOFI

Duane Clark | General Manager, US Rare Disease | SANOFI » speaking at Orphan Drug Congress

Kyle Clifton, Senior Director, Red Nucleus

Kyle Clifton | Senior Director | Red Nucleus » speaking at Orphan Drug Congress

Jason Colquitt, Chief Executive Officer, Across Healthcare

Jason Colquitt | Chief Executive Officer | Across Healthcare » speaking at Orphan Drug Congress

Matt Conway, Vice President of Strategic Initiatives, Rare Strides

Matt Conway | Vice President of Strategic Initiatives | Rare Strides » speaking at Orphan Drug Congress

Colin Cook, Technical Founder, XDemics Corporation

Colin Cook | Technical Founder | XDemics Corporation » speaking at Orphan Drug Congress

Ron Cooper, Former CEO, Albireo Pharma

Ron Cooper | Former CEO | Albireo Pharma » speaking at Orphan Drug Congress

Donna Cowan, Associate Director EAP, Stealth BioTherapeutics

Donna Cowan | Associate Director EAP | Stealth BioTherapeutics » speaking at Orphan Drug Congress

Carole Cramer, President & Founder, BioStrategies

Carole Cramer | President & Founder | BioStrategies » speaking at Orphan Drug Congress

Joslyn Crowe, Executive Director, National Niemann Pick Disease Foundation Inc

Joslyn Crowe | Executive Director | National Niemann Pick Disease Foundation Inc » speaking at Orphan Drug Congress

Andrew Cummins, VP Access and Reimbursement, Sciensus

Andrew Cummins | VP Access and Reimbursement | Sciensus » speaking at Orphan Drug Congress

Colleen Dansereau, Senior Director - Gene Therapy Program and Office of Emerging Medical Discoveries, Boston Children's Hospital

Colleen Dansereau | Senior Director - Gene Therapy Program and Office of Emerging Medical Discoveries | Boston Children's Hospital » speaking at Orphan Drug Congress

Zayd Daruwala, VP, Medical Strategy, Havas Life Rare

Zayd Daruwala | VP, Medical Strategy | Havas Life Rare » speaking at Orphan Drug Congress

Michelle Davis, Executive Director, International Fibrodysplasia Ossificans Progressiva (FOP) Association, Inc.

Michelle Davis | Executive Director | International Fibrodysplasia Ossificans Progressiva (FOP) Association, Inc. » speaking at Orphan Drug Congress

Khrystal K Davis, Founding President, Texas Rare Alliance

Khrystal K Davis | Founding President | Texas Rare Alliance » speaking at Orphan Drug Congress

Marcella Debidda, President, BioNews Clinical, BioNews Clinical

Marcella Debidda | President, BioNews Clinical | BioNews Clinical » speaking at Orphan Drug Congress

Daniel DeFabio, Rare Dad (Menkes Disease), Co-Founder, Disorder: The Rare Disease Film Festival

Daniel DeFabio | Rare Dad (Menkes Disease), Co-Founder | Disorder: The Rare Disease Film Festival » speaking at Orphan Drug Congress

Tom Defay, Deputy Head Diagnostics Strategy & Development, Alexion Pharmaceuticals

Tom Defay | Deputy Head Diagnostics Strategy & Development | Alexion Pharmaceuticals » speaking at Orphan Drug Congress

Linda Dell, VP, Program Leader, ReAlta Life Sciences, Inc.

Linda Dell | VP, Program Leader | ReAlta Life Sciences, Inc. » speaking at Orphan Drug Congress

Jin Ding, Research Fellow, University of Sheffield

Jin Ding | Research Fellow | University of Sheffield » speaking at Orphan Drug Congress

Kate Donigan, Senior Director, Science & Regulatory Policy, Global Policy, Government, & Patient Affairs, Sarepta Therapeutics

Kate Donigan | Senior Director, Science & Regulatory Policy, Global Policy, Government, & Patient Affairs | Sarepta Therapeutics » speaking at Orphan Drug Congress

Lauren Dougherty, Chief Operating Officer, TREND Community

Lauren Dougherty | Chief Operating Officer | TREND Community » speaking at Orphan Drug Congress

Kasey Edwards, Co-Founder, Community Relations Specialist, Cure AP-4

Kasey Edwards | Co-Founder, Community Relations Specialist | Cure AP-4 » speaking at Orphan Drug Congress

Leslie Edwin, President, Cushing's Support & Research Foundation

Leslie Edwin | President | Cushing's Support & Research Foundation » speaking at Orphan Drug Congress

Michael Eging, Executive Director, Rare Access Action Project

Michael Eging | Executive Director | Rare Access Action Project » speaking at Orphan Drug Congress

Sean Ekins, Chief Executive Officer, Collaborations Pharmaceuticals

Sean Ekins | Chief Executive Officer | Collaborations Pharmaceuticals » speaking at Orphan Drug Congress

Jida El Hajjar, Executive Director,, ALS Action Canada

Jida El Hajjar | Executive Director, | ALS Action Canada » speaking at Orphan Drug Congress

Alexis Elder, Board Member, Cure VCP Disease

Alexis Elder | Board Member | Cure VCP Disease » speaking at Orphan Drug Congress

Shaun Ellis, Vice President, Global Market Access Specialty Ophthalmology, Johnson & Johnson

Shaun Ellis | Vice President, Global Market Access Specialty Ophthalmology | Johnson & Johnson » speaking at Orphan Drug Congress

Terri Ellsworth, Patient Advocate Partnerships, myTomorrows

Terri Ellsworth | Patient Advocate Partnerships | myTomorrows » speaking at Orphan Drug Congress

Bastiaan Evers, Senior Director Drug Discovery, Scenic Biotech

Bastiaan Evers | Senior Director Drug Discovery | Scenic Biotech » speaking at Orphan Drug Congress

Erik Feingold, CEO & Co-Founder, FDNA, Inc

Erik Feingold | CEO & Co-Founder | FDNA, Inc » speaking at Orphan Drug Congress

James Fink, Director, Epilepsy Therapeutic Lead, Quiver Bioscience

James Fink | Director, Epilepsy Therapeutic Lead | Quiver Bioscience » speaking at Orphan Drug Congress

Alicia Fiscus, Head of Global Regulatory Affairs and QA, Rhythm Pharmaceuticals

Alicia Fiscus | Head of Global Regulatory Affairs and QA | Rhythm Pharmaceuticals » speaking at Orphan Drug Congress

Colton Flowers, NLP Engineer, TREND Community

Colton Flowers | NLP Engineer | TREND Community » speaking at Orphan Drug Congress

Pawel Fludzinski, Chief Executive Officer, AmideBio

Pawel Fludzinski | Chief Executive Officer | AmideBio » speaking at Orphan Drug Congress

Max Flurie, Senior Data Scientist, TREND Community

Max Flurie | Senior Data Scientist | TREND Community » speaking at Orphan Drug Congress

Benjamin Forred, Director of Translational Research and the CoRDS Registry, Sanford Health

Benjamin Forred | Director of Translational Research and the CoRDS Registry | Sanford Health » speaking at Orphan Drug Congress

Lindy Forte, Senior Vice President, Market Access and Pricing, EVERSANA

Lindy Forte | Senior Vice President, Market Access and Pricing | EVERSANA » speaking at Orphan Drug Congress

Jean-Pascal Fournier-Roussy, Head, Global Public Affairs, Rare Diseases & Rare Blood Disorders, Sanofi

Jean-Pascal Fournier-Roussy | Head, Global Public Affairs, Rare Diseases & Rare Blood Disorders | Sanofi » speaking at Orphan Drug Congress

Nick France, Vice President, Clinical Development, Neurology, Alexion, AstraZeneca Rare Disease

Nick France | Vice President, Clinical Development, Neurology | Alexion, AstraZeneca Rare Disease » speaking at Orphan Drug Congress

Sebastian Franzinger, Head of Business Development, Scenic Biotech

Sebastian Franzinger | Head of Business Development | Scenic Biotech » speaking at Orphan Drug Congress

Albert Freedman, Counseling Psychologist / Rare Dad, Rarecounseling.com

Albert Freedman | Counseling Psychologist / Rare Dad | Rarecounseling.com » speaking at Orphan Drug Congress

Jon Fryzek, Practice Director, EpidStrategies, A Division of ToxStrategies

Jon Fryzek | Practice Director | EpidStrategies, A Division of ToxStrategies » speaking at Orphan Drug Congress

Mike Fusakio, Lead Consultant, Regulatory Affairs, Halloran Consulting Group

Mike Fusakio | Lead Consultant, Regulatory Affairs | Halloran Consulting Group » speaking at Orphan Drug Congress

Renata Gallagher, MD, PhD, Medical Director, Parexel

Renata Gallagher, MD, PhD | Medical Director | Parexel » speaking at Orphan Drug Congress

Neha Gandhi, Consultant, Advocacy and Policy

Neha Gandhi | Consultant | Advocacy and Policy » speaking at Orphan Drug Congress

Pamela Gavin, Executive Vice President, National Organization for Rare Disorders (NORD)

Pamela Gavin | Executive Vice President | National Organization for Rare Disorders (NORD) » speaking at Orphan Drug Congress

Sarah Gheuens, Chief Medical Officer, Head of R&D, Agios Pharmaceuticals

Sarah Gheuens | Chief Medical Officer, Head of R&D | Agios Pharmaceuticals » speaking at Orphan Drug Congress

Diego Gil Cardozo, President, Enfermedades Raras en el Caribe y América Latina (ERCAL)

Diego Gil Cardozo | President | Enfermedades Raras en el Caribe y América Latina (ERCAL) » speaking at Orphan Drug Congress

Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson

Christoph Glaetzer | Chief Global Value and Access Officer | Johnson & Johnson » speaking at Orphan Drug Congress

Sarah Glass, Chief Operating Officer, n-Lorem Foundation

Sarah Glass | Chief Operating Officer | n-Lorem Foundation » speaking at Orphan Drug Congress

Josie Godfrey, Co-Founder and Chief Executive Officer, Realise Advocacy

Josie Godfrey | Co-Founder and Chief Executive Officer | Realise Advocacy » speaking at Orphan Drug Congress

Leslie Gordon, Medical Director, Progeria Research Foundation

Leslie Gordon | Medical Director | Progeria Research Foundation » speaking at Orphan Drug Congress

Deb Gouveia, SVP, Development Operations, EveryONE Medicines

Deb Gouveia | SVP, Development Operations | EveryONE Medicines » speaking at Orphan Drug Congress

Heidi Grabenstatter, Science Director, Critical Path Institute

Heidi Grabenstatter | Science Director | Critical Path Institute » speaking at Orphan Drug Congress

Nathan Grant, Researcher, Medical Student; President and Founder, Harvard Medical School; Siblings with a Mission

Nathan Grant | Researcher, Medical Student; President and Founder | Harvard Medical School; Siblings with a Mission » speaking at Orphan Drug Congress

Amy Gray, CEO, Undiagnosed Diseases Network Foundation

Amy Gray | CEO | Undiagnosed Diseases Network Foundation » speaking at Orphan Drug Congress

Brandi Greenberg, VP Marketing-Analytics & Insights, Real Chemistry

Brandi Greenberg | VP Marketing-Analytics & Insights | Real Chemistry » speaking at Orphan Drug Congress

James Griffin, Sickle Cell Patient Advocate, Independent Milwaukee Wisconsin

James Griffin | Sickle Cell Patient Advocate | Independent Milwaukee Wisconsin » speaking at Orphan Drug Congress

Gay Grossman, Co-Founder and Patient Advocate, ADCY5.org

Gay Grossman | Co-Founder and Patient Advocate | ADCY5.org » speaking at Orphan Drug Congress

Teri Hagemann, Director of Client Services, Splash Clinical

Teri Hagemann | Director of Client Services | Splash Clinical » speaking at Orphan Drug Congress

Alaa Hamed, Global Head, Medical Affairs Rare Disease and Rare Blood Disorders, Sanofi

Alaa Hamed | Global Head, Medical Affairs Rare Disease and Rare Blood Disorders | Sanofi » speaking at Orphan Drug Congress

Matthew Hanchard, Research Fellow, University of Sheffield

Matthew Hanchard | Research Fellow | University of Sheffield » speaking at Orphan Drug Congress

Kate Hanman, US Head of Rare Diseases, Costello Medical

Kate Hanman | US Head of Rare Diseases | Costello Medical » speaking at Orphan Drug Congress

Rachel Harrison, Pre-Approval Access Lead, argenx

Rachel Harrison | Pre-Approval Access Lead | argenx » speaking at Orphan Drug Congress

Sue Harvey, Founder & Chief Transformation Officer, Riverwise Leadership

Sue Harvey | Founder & Chief Transformation Officer | Riverwise Leadership » speaking at Orphan Drug Congress

Shane Hegarty, Chief Scientific Officer & Co-Founder, AXONIS Therapeutics

Shane Hegarty | Chief Scientific Officer & Co-Founder | AXONIS Therapeutics » speaking at Orphan Drug Congress

Alexandra Heumber Perry, Chief Executive Officer, Rare Diseases International

Alexandra Heumber Perry | Chief Executive Officer | Rare Diseases International » speaking at Orphan Drug Congress

Gary Ho, Senior Community Director, TREND Community

Gary Ho | Senior Community Director | TREND Community » speaking at Orphan Drug Congress

Lauren Holder, Producer/Host, Help 4 HD Live, Help 4 HD

Lauren Holder | Producer/Host, Help 4 HD Live | Help 4 HD » speaking at Orphan Drug Congress

Laura Hopkins, Associate Director, Critical Path Institute

Laura Hopkins | Associate Director | Critical Path Institute » speaking at Orphan Drug Congress

Spencer Huggett, Founder, Synapze

Spencer Huggett | Founder | Synapze » speaking at Orphan Drug Congress

Wills Hughes-Wilson, Chief Patient Access & Commercial Planning, Mereo Biopharma

Wills Hughes-Wilson | Chief Patient Access & Commercial Planning | Mereo Biopharma » speaking at Orphan Drug Congress

Huong Huynh, Director of Regulatory Science, Critical Path Institute

Huong Huynh | Director of Regulatory Science | Critical Path Institute » speaking at Orphan Drug Congress

Oxana Iliach, Member of Regulatory Science Committee, International Rare Diseases Research Consortium (IRDiRC)

Oxana Iliach | Member of Regulatory Science Committee | International Rare Diseases Research Consortium (IRDiRC) » speaking at Orphan Drug Congress

Katheron Intson, Chief Executive Officer, Varient

Katheron Intson | Chief Executive Officer | Varient » speaking at Orphan Drug Congress

Roberto Iunes, Senior Health Economist, World Bank

Roberto Iunes | Senior Health Economist | World Bank » speaking at Orphan Drug Congress

Sun-Gou Ji, Vice President of Computational Genetics, BridgeBio Pharma

Sun-Gou Ji | Vice President of Computational Genetics | BridgeBio Pharma » speaking at Orphan Drug Congress

Gretchen Jordan, Associate Director, Cushing's Support & Research Foundation

Gretchen Jordan | Associate Director | Cushing's Support & Research Foundation » speaking at Orphan Drug Congress

Lisa Jordan, Senior Vice President, Management Supervisor, Havas Life Rare

Lisa Jordan | Senior Vice President, Management Supervisor | Havas Life Rare » speaking at Orphan Drug Congress

Andria Joseph, Project Director Outcomes Research, York Health Economics Consortium

Andria Joseph | Project Director Outcomes Research | York Health Economics Consortium » speaking at Orphan Drug Congress

Christine Juday, Head, Market Access, Real Chemistry

Christine Juday | Head, Market Access | Real Chemistry » speaking at Orphan Drug Congress

Richie Kahn, Co-Founder & Principal, Canary Advisors

Richie Kahn | Co-Founder & Principal | Canary Advisors » speaking at Orphan Drug Congress

Emil Kakkis, Chief Executive Officer, Ultragenyx Pharmaceutical

Emil Kakkis | Chief Executive Officer | Ultragenyx Pharmaceutical » speaking at Orphan Drug Congress

Inderpreet Kambo, Principal (Partner) - Information Management & Analytics, IQVIA

Inderpreet Kambo | Principal (Partner) - Information Management & Analytics | IQVIA » speaking at Orphan Drug Congress

Manohar Katakam, Chief Executive Officer, SteroTherapeutics

Manohar Katakam | Chief Executive Officer | SteroTherapeutics » speaking at Orphan Drug Congress

Ken Kengatharan, Managing General Partner, Atheneos Ventures

Ken Kengatharan | Managing General Partner | Atheneos Ventures » speaking at Orphan Drug Congress

Melissa Kennedy, Chief Executive Officer, International Rett Syndrome Foundation

Melissa Kennedy | Chief Executive Officer | International Rett Syndrome Foundation » speaking at Orphan Drug Congress

Annie Kennedy, Chief of Policy, Advocacy, & Patient Engagement, EveryLife Foundation for Rare Diseases

Annie Kennedy | Chief of Policy, Advocacy, & Patient Engagement | EveryLife Foundation for Rare Diseases » speaking at Orphan Drug Congress

Adrian Kielhorn, Senior Director Health Economics and Outcomes Research, Alexion

Adrian Kielhorn | Senior Director Health Economics and Outcomes Research | Alexion » speaking at Orphan Drug Congress

Amy Kimzey, Toxicologist, EpidStrategies, A Division of ToxStrategies

Amy Kimzey | Toxicologist | EpidStrategies, A Division of ToxStrategies » speaking at Orphan Drug Congress

MARIA KIRSCH, President, Patient Services, EVERSANA

MARIA KIRSCH | President, Patient Services | EVERSANA » speaking at Orphan Drug Congress

Terri Klein, President & Chief Executive Officer, National M.P.S. Society

Terri Klein | President & Chief Executive Officer | National M.P.S. Society » speaking at Orphan Drug Congress

Jessica Klein, Rare Disease Awareness Marketer, KnoJAK Consulting

Jessica Klein | Rare Disease Awareness Marketer | KnoJAK Consulting » speaking at Orphan Drug Congress

Aki Ko, Chief Executive Officer, Elixirgen Therapeutics, Inc.

Aki Ko | Chief Executive Officer | Elixirgen Therapeutics, Inc. » speaking at Orphan Drug Congress

Bret Koncak, Co-Founder, mejo

Bret Koncak | Co-Founder | mejo » speaking at Orphan Drug Congress

Lauren Kopsick, Founder and Executive Director, The Healthcare Navigation Project

Lauren Kopsick | Founder and Executive Director | The Healthcare Navigation Project » speaking at Orphan Drug Congress

Augusta Elizabeth Koroma, Chief Executive Officer, Sickle cell Intervention U.K

Augusta Elizabeth Koroma | Chief Executive Officer | Sickle cell Intervention U.K » speaking at Orphan Drug Congress

Ivan Kouchlev, Managing Principal, Real-World Data Solutions, Real Chemistry

Ivan Kouchlev | Managing Principal, Real-World Data Solutions | Real Chemistry » speaking at Orphan Drug Congress

Rahul Kukreja, Project Director, Clinical Project Management, Allucent

Rahul Kukreja | Project Director, Clinical Project Management | Allucent » speaking at Orphan Drug Congress

Neha Kumar, Global Commercial Strategy - Precision Medicine, Johnson & Johnson Innovative Medicine

Neha Kumar | Global Commercial Strategy - Precision Medicine | Johnson & Johnson Innovative Medicine » speaking at Orphan Drug Congress

Alix Lacoste, AI Computational Biology Director Genetic Insights, Invitae

Alix Lacoste | AI Computational Biology Director Genetic Insights | Invitae » speaking at Orphan Drug Congress

Shira Landskroner-Eiger, Director, External Innovation Rare Disease, Ipsen

Shira Landskroner-Eiger | Director, External Innovation Rare Disease | Ipsen » speaking at Orphan Drug Congress

Larissa Lapteva, Associate Director, FDA

Larissa Lapteva | Associate Director | FDA » speaking at Orphan Drug Congress

Sherry Lard, PhD, Associate Director for Product Management (ADPM), U.S. Food and Drug Administration

Sherry Lard, PhD | Associate Director for Product Management (ADPM) | U.S. Food and Drug Administration » speaking at Orphan Drug Congress

Patroski Lawson, Chief Executive Officer, The KPM Group DC

Patroski Lawson | Chief Executive Officer | The KPM Group DC » speaking at Orphan Drug Congress

Yann Le Cam, Founder and past-CEO, EURORDIS

Yann Le Cam | Founder and past-CEO | EURORDIS » speaking at Orphan Drug Congress

Connie Lee, President and Chief Executive Officer, Alliance to Cure Cavernous Malformations

Connie Lee | President and Chief Executive Officer | Alliance to Cure Cavernous Malformations » speaking at Orphan Drug Congress

Michael Lehmicke, Senior Vice President of Science and Industry Affairs, Alliance for Regenerative Medicine

Michael Lehmicke | Senior Vice President of Science and Industry Affairs | Alliance for Regenerative Medicine » speaking at Orphan Drug Congress

Melanie Lendnal, Senior Vice President, Policy and Advocacy, The ALS Association

Melanie Lendnal | Senior Vice President, Policy and Advocacy | The ALS Association » speaking at Orphan Drug Congress

Maurice Leonard, Medical Director, Uniphar

Maurice Leonard | Medical Director | Uniphar » speaking at Orphan Drug Congress

William Lin, Program Director, GARDaccess, Partnership for Quality Medical Donations (PQMD)

William Lin | Program Director, GARDaccess | Partnership for Quality Medical Donations (PQMD) » speaking at Orphan Drug Congress

Andrew Lo, Charles E. and Susan T. Harris Professor, Massachusetts Institute of Technology (MIT)

Andrew Lo | Charles E. and Susan T. Harris Professor | Massachusetts Institute of Technology (MIT) » speaking at Orphan Drug Congress

Robert Long, Executive Director, Uplifting Athletes

Robert Long | Executive Director | Uplifting Athletes » speaking at Orphan Drug Congress

Veronica Lopez Gousset, MPH, Founder and President, VLG Global

Veronica Lopez Gousset, MPH | Founder and President | VLG Global » speaking at Orphan Drug Congress

Cathleen Lutz, Vice President of the Rare Disease Translational Center, Jackson Laboratory

Cathleen Lutz | Vice President of the Rare Disease Translational Center | Jackson Laboratory » speaking at Orphan Drug Congress

Gary M Hutchinson, SVP, Cold Chain Engineering, Modality Solutions

Gary M Hutchinson | SVP, Cold Chain Engineering | Modality Solutions » speaking at Orphan Drug Congress

Kim MacDonnell, Associate Director, Rare Disease, COE, Parexel

Kim MacDonnell | Associate Director, Rare Disease, COE | Parexel » speaking at Orphan Drug Congress

Donna Mackey, Vice President, Clinical Operations, Akouos, Inc.

Donna Mackey | Vice President, Clinical Operations | Akouos, Inc. » speaking at Orphan Drug Congress

Mark Manfredi, Chief Executive Officer, Ikena Oncology

Mark Manfredi | Chief Executive Officer | Ikena Oncology » speaking at Orphan Drug Congress

Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration

Peter Marks | Director, Center For Biologics Evaluation And Research (CBER) | U.S. Food and Drug Administration » speaking at Orphan Drug Congress

Silas Martin, Head, Access & Policy Research, Johnson & Johnson

Silas Martin | Head, Access & Policy Research | Johnson & Johnson » speaking at Orphan Drug Congress

Craig Martin, President, Rithm Health; CEO, Orphan Therapeutics Accelerator

Craig Martin | President, Rithm Health; CEO | Orphan Therapeutics Accelerator » speaking at Orphan Drug Congress

Jaclyn Martin, Vice President of Global Head Market Access Cell and Gene Therapy, Bayer

Jaclyn Martin | Vice President of Global Head Market Access Cell and Gene Therapy | Bayer » speaking at Orphan Drug Congress

Kristin Marvin-Keller, Managing Director, Havas Life Rare

Kristin Marvin-Keller | Managing Director | Havas Life Rare » speaking at Orphan Drug Congress

Sweety Mathew, Senior Regulatory Professional, Novo Nordisk

Sweety Mathew | Senior Regulatory Professional | Novo Nordisk » speaking at Orphan Drug Congress

Annette Maughan, CEO/Co-Founder, KBG Foundation

Annette Maughan | CEO/Co-Founder | KBG Foundation » speaking at Orphan Drug Congress

Gemma Mayman, Specialty Care Patient Solutions and Engagement Lead, Pfizer

Gemma Mayman | Specialty Care Patient Solutions and Engagement Lead | Pfizer » speaking at Orphan Drug Congress

Reenie McCarthy, Chief Executive Officer, Stealth BioTherapeutics

Reenie McCarthy | Chief Executive Officer | Stealth BioTherapeutics » speaking at Orphan Drug Congress

Alice McConnell, Chief Executive Officer, Speragen, Inc

Alice McConnell | Chief Executive Officer | Speragen, Inc » speaking at Orphan Drug Congress

Michael McGinn, Founder, CureLBSL

Michael McGinn | Founder | CureLBSL » speaking at Orphan Drug Congress

Mary McGowan, Chief Executive Officer, Foundation for Sarcoidosis Research

Mary McGowan | Chief Executive Officer | Foundation for Sarcoidosis Research » speaking at Orphan Drug Congress

Gina McHugh, Conference Producer, Terrapinn

Gina McHugh | Conference Producer | Terrapinn » speaking at Orphan Drug Congress

Kristin McKay, President/Executive Director, Project Alive

Kristin McKay | President/Executive Director | Project Alive » speaking at Orphan Drug Congress

Jennifer McNary, Founder, One Rare

Jennifer McNary | Founder | One Rare » speaking at Orphan Drug Congress

Stuart Mealing, Associate Director (HEOR), York Health Economics Consortium

Stuart Mealing | Associate Director (HEOR) | York Health Economics Consortium » speaking at Orphan Drug Congress

Laurence Mignon, Executive Director, Clinical Development, n-Lorem Foundation

Laurence Mignon | Executive Director, Clinical Development | n-Lorem Foundation » speaking at Orphan Drug Congress

Sheila Mikhail, Executive Director, Columbus Children's Foundation

Sheila Mikhail | Executive Director | Columbus Children's Foundation » speaking at Orphan Drug Congress

Tsveta Milanova, Chief Commercial Officer, Agios Pharmaceuticals

Tsveta Milanova | Chief Commercial Officer | Agios Pharmaceuticals » speaking at Orphan Drug Congress

Nicole Miller, Vice President, Molecular Diagnostics, Global Medical Affairs, Ultragenyx

Nicole Miller | Vice President, Molecular Diagnostics, Global Medical Affairs | Ultragenyx » speaking at Orphan Drug Congress

Nicola Miller, Editor in Chief, RARE Revolution Magazine

Nicola Miller | Editor in Chief | RARE Revolution Magazine » speaking at Orphan Drug Congress

Juliane Mills, Senior Director, Therapeutic Strategy Lead, Rare Disease, Worldwide Clinical Trials

Juliane Mills | Senior Director, Therapeutic Strategy Lead, Rare Disease | Worldwide Clinical Trials » speaking at Orphan Drug Congress

Samarendra Mohanty, Founder-President, Chief Scientific Officer, Nanoscope Therapeutics

Samarendra Mohanty | Founder-President, Chief Scientific Officer | Nanoscope Therapeutics » speaking at Orphan Drug Congress

James Mongiardo, Chief Executive Officer, A-Synaptic Corp.

James Mongiardo | Chief Executive Officer | A-Synaptic Corp. » speaking at Orphan Drug Congress

Mary Morlino, Patient Navigator, Undiagnosed Disease Network Foundation (UDNF)

Mary Morlino | Patient Navigator | Undiagnosed Disease Network Foundation (UDNF) » speaking at Orphan Drug Congress

Lindsay Murphy, Senior Group Director, Integrated Intelligence, Real Chemistry

Lindsay Murphy | Senior Group Director, Integrated Intelligence | Real Chemistry » speaking at Orphan Drug Congress

Joe Musumeci, President, BluePrint Orphan

Joe Musumeci | President | BluePrint Orphan » speaking at Orphan Drug Congress

Ramaiah Muthyala, Professor/Director at University of Minnesota, President and Chief Executive Officer,, Indian organization for Rare diseases

Ramaiah Muthyala | Professor/Director at University of Minnesota, President and Chief Executive Officer, | Indian organization for Rare diseases » speaking at Orphan Drug Congress

Ramaa Nathan, VP of Data Science and Real-World Evidence, EVERSANA

Ramaa Nathan | VP of Data Science and Real-World Evidence | EVERSANA » speaking at Orphan Drug Congress

Alexander Natz, Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Alexander Natz | Director General | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs » speaking at Orphan Drug Congress

Neena Nizar, Assoc. Director, Patient Advocacy Strategy, ICON Centre for Rare Diseases; President, The Jansens Foundation

Neena Nizar | Assoc. Director, Patient Advocacy Strategy, ICON Centre for Rare Diseases; President | The Jansens Foundation » speaking at Orphan Drug Congress

Greg Palko, Vice President, North America Oncology Region Franchise Head, Kyowa Kirin

Greg Palko | Vice President, North America Oncology Region Franchise Head | Kyowa Kirin » speaking at Orphan Drug Congress

Jim Palma, Chief Executive Officer, TargetCancer Foundation

Jim Palma | Chief Executive Officer | TargetCancer Foundation » speaking at Orphan Drug Congress

Effie Parks, Podcast Host, Director of Parnerships, Once Upon A Gene - CTNNB1

Effie Parks | Podcast Host, Director of Parnerships | Once Upon A Gene - CTNNB1 » speaking at Orphan Drug Congress

Kinnari Patel, President & COO, Rocket Pharma

Kinnari Patel | President & COO | Rocket Pharma » speaking at Orphan Drug Congress

Dave Pearce, Chair, International Rare Diseases Research Consortium (IRDiRC)

Dave Pearce | Chair | International Rare Diseases Research Consortium (IRDiRC) » speaking at Orphan Drug Congress

Melissa Penn, Director Patient Engagement Research & Development, Bayer

Melissa Penn | Director Patient Engagement Research & Development | Bayer » speaking at Orphan Drug Congress

Sue Peschin, President and Chief Executive Officer, Alliance for Aging Research

Sue Peschin | President and Chief Executive Officer | Alliance for Aging Research » speaking at Orphan Drug Congress

Steven Peskin, President and Chief Executive Officer; Former Executive Medical Director Population Health, Horizon Blue Cross Blue Shield of NJ, SRP Advisors, LLC

Steven Peskin | President and Chief Executive Officer; Former Executive Medical Director Population Health, Horizon Blue Cross Blue Shield of NJ | SRP Advisors, LLC » speaking at Orphan Drug Congress

Maria Picone, Chief Executive Officer, TREND Community

Maria Picone | Chief Executive Officer | TREND Community » speaking at Orphan Drug Congress

Armelle Pindon, Chief Scientific Officer, Cure VCP Disease

Armelle Pindon | Chief Scientific Officer | Cure VCP Disease » speaking at Orphan Drug Congress

Peter Pitts, President, C.M.P.I

Peter Pitts | President | C.M.P.I » speaking at Orphan Drug Congress

Christopher Porter, Vice President, Government Affairs and Policy, Travere Therapeutics

Christopher Porter | Vice President, Government Affairs and Policy | Travere Therapeutics » speaking at Orphan Drug Congress

Otto Prohaska, Founder and Chief Executive Officer, Transcytos

Otto Prohaska | Founder and Chief Executive Officer | Transcytos » speaking at Orphan Drug Congress

XENIA PROTON DE LA CHAPELLE, Chief Executive Officer and Patient Representative, AtmosR

XENIA PROTON DE LA CHAPELLE | Chief Executive Officer and Patient Representative | AtmosR » speaking at Orphan Drug Congress

Harsha Rajasimha, Founder and Chairman, IndoUSrare

Harsha Rajasimha | Founder and Chairman | IndoUSrare » speaking at Orphan Drug Congress

Harpreet Ram, President, EVR Consulting

Harpreet Ram | President | EVR Consulting » speaking at Orphan Drug Congress

Dorian Readnour, Executive Director, Global Patient Access, Sarepta Therapeutics

Dorian Readnour | Executive Director, Global Patient Access | Sarepta Therapeutics » speaking at Orphan Drug Congress

Debra Regier, Director, Rare Disease Institute, Children's National Hospital

Debra Regier | Director, Rare Disease Institute | Children's National Hospital » speaking at Orphan Drug Congress

Deborah Requesens, Director, JumpStart, Orphan Disease Center, University of Pennsylvania, Perelman School of Medicine

Deborah Requesens | Director, JumpStart | Orphan Disease Center, University of Pennsylvania, Perelman School of Medicine » speaking at Orphan Drug Congress

Joshua Resnikoff, Chief Executive Officer, TMA precision health

Joshua Resnikoff | Chief Executive Officer | TMA precision health » speaking at Orphan Drug Congress

Jamie Ring, Founder, Jamie Ring Advocacy Consulting

Jamie Ring | Founder | Jamie Ring Advocacy Consulting » speaking at Orphan Drug Congress

Shawn Ritchie, Chief Executive Officer, Med-Life Discoveries

Shawn Ritchie | Chief Executive Officer | Med-Life Discoveries » speaking at Orphan Drug Congress

Frank Rivera, President, Stronger Than Sarcoidosis

Frank Rivera | President | Stronger Than Sarcoidosis » speaking at Orphan Drug Congress

Afshan Rizvi Hussain, Managing Director, Global Rare Disease Lead, Havas Health

Afshan Rizvi Hussain | Managing Director, Global Rare Disease Lead | Havas Health » speaking at Orphan Drug Congress

Brigitte Roberts, Director, Program Management, Comcast

Brigitte Roberts | Director, Program Management | Comcast » speaking at Orphan Drug Congress

Derek Robertson, President, Maryland Sickle Cell Disease Association

Derek Robertson | President | Maryland Sickle Cell Disease Association » speaking at Orphan Drug Congress

Christopher Robertson, Professor of Law, Boston University

Christopher Robertson | Professor of Law | Boston University » speaking at Orphan Drug Congress

Devin Rosenthal, Vice President & Head of Due Diligence, NovaQuest Capital Management

Devin Rosenthal | Vice President & Head of Due Diligence | NovaQuest Capital Management » speaking at Orphan Drug Congress

Heidi Ross, Vice President of Policy and Regulatory Affairs, National Organization for Rare Disorders

Heidi Ross | Vice President of Policy and Regulatory Affairs | National Organization for Rare Disorders » speaking at Orphan Drug Congress

Ruth Rostron, Director of Program Management, Uniphar

Ruth Rostron | Director of Program Management | Uniphar » speaking at Orphan Drug Congress

Ronenn Roubenoff, Consultant, Ronenn Roubenoff

Ronenn Roubenoff | Consultant | Ronenn Roubenoff » speaking at Orphan Drug Congress

Yury Rozenman, SVP of Business Development Life Sciences, Ada Health

Yury Rozenman | SVP of Business Development Life Sciences | Ada Health » speaking at Orphan Drug Congress

Christopher Rudolf, Founder and Chief Executive Officer, volv global

Christopher Rudolf | Founder and Chief Executive Officer | volv global » speaking at Orphan Drug Congress

Pierantonio Russo, FCCP, FAAP, STS, Corporate Chief Medical Officer, EVERSANA

Pierantonio Russo, FCCP, FAAP, STS | Corporate Chief Medical Officer | EVERSANA » speaking at Orphan Drug Congress

Naomi Sacks, Principal Scientist, HEORStrategies, A Division of ToxStrategies LLC

Naomi Sacks | Principal Scientist | HEORStrategies, A Division of ToxStrategies LLC » speaking at Orphan Drug Congress

Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU), National Institute of Health (NIH)

Michael Salgaller | Supervisor, Technology Analysis and Marketing Unit (TAMU) | National Institute of Health (NIH) » speaking at Orphan Drug Congress

Matt Salo, Former Executive Director, National Association of Medicaid Directors (NAMD), Founder and Chief Executive Officer, Salo Health Strategies

Matt Salo | Former Executive Director, National Association of Medicaid Directors (NAMD), Founder and Chief Executive Officer | Salo Health Strategies » speaking at Orphan Drug Congress

Peter Saltonstall, Chief Executive Officer, National Organization for Rare Disorders (NORD)

Peter Saltonstall | Chief Executive Officer | National Organization for Rare Disorders (NORD) » speaking at Orphan Drug Congress

Dick Salvatierra, President, Americas Health Foundation

Dick Salvatierra | President | Americas Health Foundation » speaking at Orphan Drug Congress

Rachael Sawaya, Associate Director, Project Management – Execution, PCM Trials

Rachael Sawaya | Associate Director, Project Management – Execution | PCM Trials » speaking at Orphan Drug Congress

Anthony Scatamacchia, Senior Vice President, Innovation, Patient Services, Eversana

Anthony Scatamacchia | Senior Vice President, Innovation, Patient Services | Eversana » speaking at Orphan Drug Congress

Mary Schaheen, President, Prevail Partners Llc

Mary Schaheen | President | Prevail Partners Llc » speaking at Orphan Drug Congress

Charles Schmidt, Senior Medical Advisor, iNSTITUTO JÔ CLEMENTE

Charles Schmidt | Senior Medical Advisor | iNSTITUTO JÔ CLEMENTE » speaking at Orphan Drug Congress

Matthias P. Schönermark, M.D., Ph., Managing Director, SKC Beratungsgesellschaft mbH

Matthias P. Schönermark, M.D., Ph. | Managing Director | SKC Beratungsgesellschaft mbH » speaking at Orphan Drug Congress

Carolyn Schwartz, President and Chief Scientist, DeltaQuest Foundation

Carolyn Schwartz | President and Chief Scientist | DeltaQuest Foundation » speaking at Orphan Drug Congress

Denise Scots Knight, Chief Executive Officer, Mereo Biopharma

Denise Scots Knight | Chief Executive Officer | Mereo Biopharma » speaking at Orphan Drug Congress

Simone Seiter, Senior Partner, Simon-Kucher & Partners Strategy & Marketing Consultants GmbH

Simone Seiter | Senior Partner | Simon-Kucher & Partners Strategy & Marketing Consultants GmbH » speaking at Orphan Drug Congress

Albert Seymour, President & Chief Executive Officer, Homology Medicines

Albert Seymour | President & Chief Executive Officer | Homology Medicines » speaking at Orphan Drug Congress

Amit Sharma, Vice President Clinical Development - Global Therapeutic Area Head Nephrology & Hematology, Alexion Pharmaceuticals

Amit Sharma | Vice President Clinical Development - Global Therapeutic Area Head Nephrology & Hematology | Alexion Pharmaceuticals » speaking at Orphan Drug Congress

Ryan Sheedy, Founder, mejo

Ryan Sheedy | Founder | mejo » speaking at Orphan Drug Congress

Darlene Shelton, President/Founder, Danny’s Dose Alliance

Darlene Shelton | President/Founder | Danny’s Dose Alliance » speaking at Orphan Drug Congress

Michael Sherman, MD, MBA, MS, Venture Partner, RA Capital Management

Michael Sherman, MD, MBA, MS | Venture Partner | RA Capital Management » speaking at Orphan Drug Congress

Tricha Shivas, Chief Strategy Officer, Foundation for Sarcoidosis Research

Tricha Shivas | Chief Strategy Officer | Foundation for Sarcoidosis Research » speaking at Orphan Drug Congress

John Sholar, Chief Executive Officer, jCyte Inc

John Sholar | Chief Executive Officer | jCyte Inc » speaking at Orphan Drug Congress

Mridula Shukla, Head of Regulatory Affairs, Gene Therapy, Poseida Therapeutics, Inc.

Mridula Shukla | Head of Regulatory Affairs, Gene Therapy | Poseida Therapeutics, Inc. » speaking at Orphan Drug Congress

Amanda Singleton, Biopharma Partnerships, GeneDx

Amanda Singleton | Biopharma Partnerships | GeneDx » speaking at Orphan Drug Congress

Jayson Slotnik, Partner, Health Policy Strategies, LLC

Jayson Slotnik | Partner | Health Policy Strategies, LLC » speaking at Orphan Drug Congress

Rachel Smith, Global Head, Rare Disease, Parexel

Rachel Smith | Global Head, Rare Disease | Parexel » speaking at Orphan Drug Congress

Laura Smith van Carroll, Head of Insight & Advocacy, Metabolic Support UK

Laura Smith van Carroll | Head of Insight & Advocacy | Metabolic Support UK » speaking at Orphan Drug Congress

Oskar Smrzka, Chief Executive Officer/CSO, Ablevia

Oskar Smrzka | Chief Executive Officer/CSO | Ablevia » speaking at Orphan Drug Congress

Frank Sorgi, President and Chief Executive Officer, FLAG Therapeutics

Frank Sorgi | President and Chief Executive Officer | FLAG Therapeutics » speaking at Orphan Drug Congress

Rodica Stan, Senior Project Manager, NIH/NCATS

Rodica Stan | Senior Project Manager | NIH/NCATS » speaking at Orphan Drug Congress

Paul Stanton, Senior Director, Global Strategy, Early Access, Inceptua Group

Paul Stanton | Senior Director, Global Strategy, Early Access | Inceptua Group » speaking at Orphan Drug Congress

Kim Stephens, Executive Director, Muenzer MPS Research & Treatment Center

Kim Stephens | Executive Director | Muenzer MPS Research & Treatment Center » speaking at Orphan Drug Congress

Dean Suhr, President and co-Founder, MLD Foundation

Dean Suhr | President and co-Founder | MLD Foundation » speaking at Orphan Drug Congress

Jamie Sullivan, Vice President of Public Policy, EveryLife Foundation for Rare Diseases

Jamie Sullivan | Vice President of Public Policy | EveryLife Foundation for Rare Diseases » speaking at Orphan Drug Congress

Donna Sullivan, Director Of Patient Advocacy, Pathways To Trust

Donna Sullivan | Director Of Patient Advocacy | Pathways To Trust » speaking at Orphan Drug Congress

Marshall Summar, Chief Executive Officer, Uncommon Cures

Marshall Summar | Chief Executive Officer | Uncommon Cures » speaking at Orphan Drug Congress

Laura Tadvalkar, Managing Director, RA Capital Management

Laura Tadvalkar | Managing Director | RA Capital Management » speaking at Orphan Drug Congress

Julia Taravella, Exececutive Director, Rare Trait Hope Fund

Julia Taravella | Exececutive Director | Rare Trait Hope Fund » speaking at Orphan Drug Congress

Jason Tardio, Chief Operating Officer, Ovid Therapeutics

Jason Tardio | Chief Operating Officer | Ovid Therapeutics » speaking at Orphan Drug Congress

Matt Teuteberg, President/ CEO, Splash Clinical

Matt Teuteberg | President/ CEO | Splash Clinical » speaking at Orphan Drug Congress

Pete Thornton, VP, Pharma Services & Strategic Partnerships, Invitae

Pete Thornton | VP, Pharma Services & Strategic Partnerships | Invitae » speaking at Orphan Drug Congress

Maria Törnsén, President, North America, Calliditas Therapeutics

Maria Törnsén | President, North America | Calliditas Therapeutics » speaking at Orphan Drug Congress

Mark Trusheim, Strategic Director NEWDIGS, Center for Biomedical System Design, Tufts Medical Center

Mark Trusheim | Strategic Director NEWDIGS, Center for Biomedical System Design | Tufts Medical Center » speaking at Orphan Drug Congress

Anthy Tsatoumas, Manager, Project Management, Veristat

Anthy Tsatoumas | Manager, Project Management | Veristat » speaking at Orphan Drug Congress

Andrew Udell, President of North America, Commercial, Calliditas Therapeutics

Andrew Udell | President of North America, Commercial | Calliditas Therapeutics » speaking at Orphan Drug Congress

Nicholas Valle, Senior Product Director, iTakeControl, Red Nucleus

Nicholas Valle | Senior Product Director, iTakeControl | Red Nucleus » speaking at Orphan Drug Congress

Jytte van Huijstee, Director Clinical Trial Operations, myTomorrows

Jytte van Huijstee | Director Clinical Trial Operations | myTomorrows » speaking at Orphan Drug Congress

Leon van Wouwe, Clinical Innovation Director, volv global

Leon van Wouwe | Clinical Innovation Director | volv global » speaking at Orphan Drug Congress

Lavni Varyani, Founder, Pharma Business Partners

Lavni Varyani | Founder | Pharma Business Partners » speaking at Orphan Drug Congress

Geeta Vemuri, Managing Partner, Agent Capital

Geeta Vemuri | Managing Partner | Agent Capital » speaking at Orphan Drug Congress

Raghu Vishwanath, Global Head, Franchise Strategy and Operations, Rare Diseases Specialty Care, SANOFI

Raghu Vishwanath | Global Head,  Franchise Strategy and Operations, Rare Diseases Specialty Care | SANOFI » speaking at Orphan Drug Congress

Lindsey Wahlstrom-Edwards, Partnerships Lead, Sano Genetics

Lindsey Wahlstrom-Edwards | Partnerships Lead | Sano Genetics » speaking at Orphan Drug Congress

Daniel Wainstock, Researcher and Rare Disease Advocate, PUC-Rio

Daniel Wainstock | Researcher and Rare Disease Advocate | PUC-Rio » speaking at Orphan Drug Congress

Mary Wang, Programme Director, Rare Diseases International

Mary Wang | Programme Director | Rare Diseases International » speaking at Orphan Drug Congress

Albert Wang, Co-founder, CEO, Comend

Albert Wang | Co-founder, CEO | Comend » speaking at Orphan Drug Congress

Jon Weber, Senior Director of Cell & Gene Therapies Access Lead, Bayer

Jon Weber | Senior Director of Cell & Gene Therapies Access Lead | Bayer » speaking at Orphan Drug Congress

Michael Weickert, Chief Executive Officer, Pacylex Pharmaceuticals

Michael Weickert | Chief Executive Officer | Pacylex Pharmaceuticals » speaking at Orphan Drug Congress

Patricia Weltin, Chief Executive Officer, Beyond the Diagnosis

Patricia Weltin | Chief Executive Officer | Beyond the Diagnosis » speaking at Orphan Drug Congress

Melissa Williams, Founder, Simply Patient

Melissa Williams | Founder | Simply Patient » speaking at Orphan Drug Congress

Ben Willis, Director of Business Excellence, Egetis Therapeutics

Ben Willis | Director of Business Excellence | Egetis Therapeutics » speaking at Orphan Drug Congress

Richard Wilson, SVP North America Rare Disease Franchise Head, Kyowa Kirin

Richard Wilson | SVP North America Rare Disease Franchise Head | Kyowa Kirin » speaking at Orphan Drug Congress

Kasey Woleben, Founder, Cure Mito Foundation/Rare Village

Kasey Woleben | Founder | Cure Mito Foundation/Rare Village » speaking at Orphan Drug Congress

Kristin Viswanathan Wolff, Senior Director, Global Government Affairs And Public Policy, bluebird bio

Kristin Viswanathan Wolff | Senior Director, Global Government Affairs And Public Policy | bluebird bio » speaking at Orphan Drug Congress

Durhane Wong-Rieger, President, Chief Executive Officer & Chair, Canadian Organisation for Rare Disorder & Rare Diseases International

Durhane Wong-Rieger | President, Chief Executive Officer & Chair | Canadian Organisation for Rare Disorder & Rare Diseases International » speaking at Orphan Drug Congress

Justin Yang, Co-Founder, Kaibab Health & DMV Bio

Justin Yang | Co-Founder | Kaibab Health & DMV Bio » speaking at Orphan Drug Congress

Christine Yu, Chief Executive Officer, P2P Syncro

Christine Yu | Chief Executive Officer | P2P Syncro » speaking at Orphan Drug Congress

Samantha Zappia, MS, RAC, Principal Consultant, SK Regulatory Solutions

Samantha Zappia, MS, RAC | Principal Consultant | SK Regulatory Solutions » speaking at Orphan Drug Congress

Sophia Zilber, Board member, patient registry director, Cure Mito Foundation

Sophia Zilber | Board member, patient registry director | Cure Mito Foundation » speaking at Orphan Drug Congress

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 
 

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

 

Marketing & Press

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com